CoStasis hemostat

CoStasis® hemostat

Surgery An atraumatic, bioresorbable, liquid hemostat spray to control bleeding in hepatic, orthopedic, cardiothoracic, and general surgical procedures
References in periodicals archive ?
Patient enrollment in a pivotal European clinical study with CoStasis hemostat for bleeding in cardiothoracic surgery has been completed, and recently Cohesion Technologies filed a design dossier in preparation for obtaining a CE Mark for CoStasis hemostat, which would allow for market entry in Europe.
CoStasis hemostat is in a pivotal clinical study in the U.
Amid this activity, AT posted 25% top-line growth and a 67% increase in operating income from operations before a non-recurring restructuring charge, and CT made excellent clinical and pre-clinical progress with CoStasis hemostat and CoSeal(TM) surgical sealant, respectively.
clinical study in hepatic, orthopedic, cardiothoracic and general surgery for CoStasis hemostat, a sprayable atraumatic product to treat bleeding.
9 million in research and development, including the continuation of a European clinical study in cardiothoracic surgery for CoStasis hemostat, a sprayable atraumatic product to treat bleeding.
We are very pleased with the performance of CoStasis hemostat in our pivotal European study currently underway and we plan to file for CE Mark by the end of 1998," said David Foster, chief executive officer of Cohesion Technologies.